- Research article
- Open Access
Expression patterns of Neil3 during embryonic brain development and neoplasia
© Hildrestrand et al; licensee BioMed Central Ltd. 2009
Received: 13 February 2009
Accepted: 09 May 2009
Published: 09 May 2009
The base excision repair pathway is responsible for repairing small DNA base lesions caused by endogenous and exogenous damaging agents. Repair is initiated by DNA glycosylases that recognize and remove the lesions. NEIL3 is one of 11 mammalian DNA glycosylases identified to date and it was discovered on the basis of sequence homology to the E. coli Fpg and Nei glycosylases. Difficulties in purifying the protein have limited its biochemical characterization and in contrast to the other glycosylases, its function remains unclear.
In this study we describe the expression pattern of Neil3 during mouse embryonic development with special focus on brain development. We have also looked at the expression of NEIL3 in several normal and tumor tissues. Quantitative real-time PCR and in situ hybridization revealed that Neil3 was highly expressed at embryonic days 12–13, when neurogenesis starts. The expression decreased during development and in the adult brain,Neil3 could not be detected in any of the brain areas examined by quantitative real-time PCR. During embryogenesis and in newborn mice specific expression was observed in areas known to harbour neural stem and progenitor cells such as the subventricular zone and the dentate gyrus. Finally, NEIL3 expression was higher in tumors compared to normal tissues, except for testis and pancreas.
Our findings indicate that mammalian NEIL3 is specifically expressed in brain areas where neurogenesis takes place during development and that its expression is tightly regulated both temporally and spatially. In addition, NEIL3 seems to be upregulated in tumor tissues compared to normal tissues. Altogether, mammalian NEIL3 seems to be highly expressed in cells with high proliferative potential.
The base excision repair (BER) pathway, one of the major DNA repair pathways, is dedicated to the repair of damaged DNA bases arising from endogenous and exogenous insults [1–4]. The DNA bases may be subjected to oxidation, alkylation and deamination and oxidative DNA damage, in particular, has been implicated in the pathogenesis of many diseases including cancer, atherosclerosis, neurodegenerative diseases such as Parkinson's and Alzheimer's, and even aging [5–8]. DNA glycosylases are the key enzymes of BER; they initiate repair by catalysing the hydrolysis of the N-glycosylic bond between modified bases and the sugar-phosphate backbone [1, 3, 4, 9]. To date, four mammalian DNA glycosylases that recognize and excise oxidized bases have been thoroughly characterized: OGG1, NTH1, NEIL1 and NEIL2 [10–12]. NEIL3 was identified together with NEIL1 and NEIL2 as a gene product with significant structural similarities to the E. coli Fpg and Nei DNA glycosylases [13–15]. However, in contrast to NEIL1 and NEIL2 no substantial DNA glycosylase activity has been detected [13, 14, 16, 17]. Expression of human NEIL3 has been reported in thymus and testis, while mouse Neil3 has been demonstrated to be highly expressed in spleen, bone marrow, thymus, blood cells and brain regions that harbour progenitor cells [13, 18, 19]. NEIL3 has also been shown to be highly expressed in primary malignant melanomas associated with metastasis . Most studies have been performed on adult organs and a recent paper described Neil3 expression in the developing mouse . Here, we describe the expression pattern of Neil3 during embryonic development in mice with focus on the expression of Neil3 during brain development. The expression of NEIL3 in multiple human cancers was also examined.
Neil3 is expressed during embryogenesis
Neil3 is highly expressed in developing brain
Neil 3 is highly expressed in regions of active neurogenesis in the developing brain
NEIL3 is expressed in various tumor samples
In this study the expression of Neil3 during embryonic brain development was investigated. Our results showed that Neil3 was not uniformly expressed in the brain, but limited to specific cells in certain regions. The expression appeared to be tightly regulated both spatially and temporally during brain development.
Results from Northern blot analysis of total embryos revealed the presence of Neil3 after E7, while RT-PCR experiments showed the presence of Neil3 in the developing brain from E9. Thus, the expression of Neil3 appears to coincide with organogenesis. This is also supported by the in silico analysis, where Neil3 transcripts were not detected until E8.5–E11.5. Intriguingly, the in silico analysis revealed high expression of Neil3 during preimplantation. Mammalian embryos undergo major changes in their gene expression patterns throughout most stages of preimplantation development and massive maternal degradation of mRNA characterizes the transition from oocyte to early embryo before the onset of new transcription [21, 22]. Genes that follow this expression pattern are suggested to have specific functions either in oogenesis, oocyte maturation, fertilization, and/or early phases of preimplantation development [23–25]. Our results suggest that Neil3 can be classified with this group of genes since Neil3 mRNA is highly expressed in unfertilised eggs and is abundant up to the zygote stadium before it is apparently degraded.
In mice, embryonic neurogenesis occurs from E12 to E17 [26, 27]. There are two major proliferative populations in the developing brain . The first to appear is a region called the ventricular zone (VZ) in the lateral ventricle. The VZ is lined by a population of cells that contains multipotent neural stem cells that give rise to most neurons and glial cells of the cortex. These cortical precursor cells constitute a heterogeneous population and there is increasing evidence that different precursor cells generate distinct differentiated cell types [29–33]. Another proliferative population is found in the subventricular zone (SVZ), located adjacent to the VZ along the lateral ventricle. Notably, neurogenesis continues in this region throughout adulthood, and in the adult mammalian brain, new neurons born in the SVZ migrate anteriorly into the olfactory bulb (OB), where they mature [34–36]. In post-natal mice, a second germinal zone exists; the subgranular zone (SGZ) of dentate gyrus in the hippocampus [36, 37]. Our in situ results showed that during brain development Neil3 was highly expressed in cells found in places rich in neural progenitors such as the VZ and the SVZ. The expression decreased during embryonic development and at P0, only a few cells around the lateral ventricles and in the dentate gyrus of the hippocampus were positive for Neil3 expression. We have recently described the distribution of Neil3 during postnatal development and found Neil3 expression in the SVZ, the rostral migratory stream (RMS), the dentate gyrus of the hippocampal formation and the Purkinje cells of the cerebellum in P3 mice. The expression of Neil3 decreased dramatically in postnatal mice so that in 1-month-old mice only a few cells in the SVZ and in layer V of neocortex were detected. In 1-year-old mice Neil3 was detected in layer V of neocortex only . In the present study no Neil3 expression was detected in brains from 5-week-old mice when using quantitative real-time PCR. The discrepancy between our results and the previously reported data could be due to a lower sensitivity of real-time PCR compared to in situ hybridization. Thus, the limited number of Neil3-positive cells detected in 1-month-old mice by in situ hybridization is probably below the detection limit of the real-time PCR. Altogether, previous data and results presented here suggest that Neil3 is highly expressed in regions where neurogenesis occurs during embryogenesis and to a lesser extent in neonatal animals . Hippocampal Neil3 expression disappeared in 1-month-old mice but could still be observed in the SVZ . This may suggest the existence of different progenitors in the two germinal areas. Since Neil3 appears to be enhanced in proliferating cells, the decline in Neil3 expression during development could be due to a decline in cell proliferation.
Neil3 knockout mice were generated a few years ago and these mice are viable and remain apparently healthy into adulthood with no overt phenotype . A putative role in lymphocytes and/or other immune cells has been proposed since Neil3 is highly expressed in lymphatic cells and tissues and the knockout mice have a slightly reduced number of blood cells . The expression pattern described in this paper warrants a closer examination of the distribution/phenotype of neural progenitor cells in the embryo and adult Neil3 knockout mice. Studies using the Neil3 knockout mice model that involve insults to the brain such as ischemic stroke would be central in revealing whether Neil3 has a role in the regeneration of damaged tissue.
In a recent study, NEIL3 was shown to be overexpressed in primary melanomas giving rise to metastasis . NEIL3 was therefore suggested to be associated with the progression of primary melanoma to distant metastasis . Interestingly, we found increased NEIL3 expression in 16 of 18 cancer tissues compared to normal tissues. Intriguingly, NEIL3 has also recently been suggested to be a host factor for HIV and thus, a target for antiviral medicines . Taken together all these observations and the fact that no robust DNA glycosylase activity has been detected [16, 17], indicate that NEIL3 is not a typical DNA glycosylase but rather a protein involved in processes where extensive proliferation is a hallmark such as brain development and possibly tumor development/progression.
We have characterized the expression pattern of Neil 3 during embryonic development. Our results clearly showed that the expression of Neil3 appeared to be tightly regulated both temporally and spatially. High expression was detected in the oocytes and preimplantation stages of development and later during organogenesis. In the embryonic brain, Neil3 was detected in sites rich in neural stem/progenitor cells. Finally, tumor tissues were shown to express higher amounts of NEIL3 compared to their normal counterparts, except for testis and pancreas. These results call for a closer examination of the brains of Neil3 knock-out mice not only during development and aging, but also under detrimental conditions such as ischemic stress.
Northern Blot Analysis
A mouse embryo MTN blot purchased from Clontech (catalog no. 7763-1) was probed for Neil3 expression. Northern blot hybridization was carried out using ExpressHyb solution (Clontech) and probes were labeled using the Rediprime DNA labeling system (Amersham Biosciences), both according to the manufacturer's protocol. The full-length murine cDNA was used as a probe.
Real-time Quantitative PCR
Messenger RNA was isolated from the brains of embryos and newborn mice (mixed background: 50% 129Sv and 50% C57BL/6) using the Dynabeads mRNA DIRECT Kit (Dynal). The RNA was treated with TurboDNase (Applied Biosystems) and cDNA synthesized using the High-Capacity cDNA Reverse Transcription kit (Applied Biosytems). The expression of glyceraldehyde-3-phosphate dehydrogenase (Gapdh) mRNA was used as endogenous control. Primers used: mouse Gapdh, forward 5'-TCG TCC CGT AGA CAA AAT GGT-3'-, reverse 5'-CGC CCA ATA CGG CCA AA-3'. Mouse Neil3, forward 5'-GGG CAA CAT CAT CAA AAA TGA A-3', reverse 5'-CTG TTT GTC TGA TAG TTG ACA CAC CTT-3'. Quantitative real-time PCR was performed in 20-μl reactions containing 20 ng of cDNA using the Power SYBR Green PCR master mix and the Step One Plus real-time PCR system (both from Applied Biosystems) according to the system and kit instructions. Relative gene expression was calculated using the comparative CT method and primers were designed using the Primer Express software version 2.0 (Applied Biosystems).
To investigate more specifically the expression of Neil3 in the developing mouse brain, a Mouse Developmental Tissue qPCR array (MDRT101; OriGene Technologies) was used. Neil3 primers used were the same as mentioned above. The array contained normalized cDNA prepared from various brain regions at five developmental stages. The cDNAs were normalized against Gapdh. Relative gene expression was calculated using the comparative CT method. The data presented are relative Neil3 mRNA levels.
For measurement of NEIL3 mRNA expression in normal and tumor tissues, we used a Disease Tissue qPCR array (CSRT303; OriGene Technologies). This array consisted of normalized cDNA prepared from pathologist-verified human tumor tissues obtained from 18 different tissues. The cDNAs were normalized against β-actin. Clinical information associated with each of these samples can be found in Additional file 1. Primers used: Human NEIL3, forward 5'-GGT CTC CAC CCA GCT GTT AAA G-3', reverse 5'-CAC GTA TCA TTT TCA TGA GGT GAT G-3'. Two parallel experiments were run and the raw data is presented in the additional file 1. Relative gene expression was calculated using the comparative CT method. The data presented are relative NEIL3 mRNA levels.
In situ hybridization
For characterization of Neil3 gene expression in the brain, wild type (C57BL6/CBA F1 strain) embryos and newborn mice were used. Coronal cryosections were prepared and in situ hybridization was performed as previously described . A plasmid containing full-length mNeil3 (clone 4945750; Invitrogen,) was linearized with appropriate enzymes before sense and antisense riboprobes were synthesized using a DIG RNA labeling kit (SP6/T7) (catalog no. 1175025; Roche).
We are grateful to Dr. Mattias Backman (University of Umeå, Sweden) for helpful technical assistance. This work was supported through the Norwegian Center for Stem Cell Research by the Research Council of Norway and The European Union Program DNA Repair.
- Barnes DE, Lindahl T: Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet. 2004, 38: 445-476. 10.1146/annurev.genet.38.072902.092448.View ArticlePubMedGoogle Scholar
- Baute J, Depicker A: Base excision repair and its role in maintaining genome stability. Crit Rev Biochem Mol Biol. 2008, 43: 239-276. 10.1080/10409230802309905.View ArticlePubMedGoogle Scholar
- Zharkov DO: Base excision DNA repair. Cell Mol Life Sci. 2008, 65: 1544-1565. 10.1007/s00018-008-7543-2.View ArticlePubMedGoogle Scholar
- Hegde ML, Hazra TK, Mitra S: Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells. Cell Res. 2008, 18: 27-47. 10.1038/cr.2008.8.PubMed CentralView ArticlePubMedGoogle Scholar
- Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006, 160: 1-40. 10.1016/j.cbi.2005.12.009.View ArticlePubMedGoogle Scholar
- Gamkrelidze M, Mamamtavrishvili N, Bejitashvili N, Sanikidze T, Ratiani L: Role of oxidative stress in pathogenesis of atherosclerosis. Georgian Med News. 2008, 163: 54-57.PubMedGoogle Scholar
- Martin LJ: DNA damage and repair: relevance to mechanisms of neurodegeneration. J Neuropathol Exp Neurol. 2008, 67: 377-387. 10.1097/NEN.0b013e31816ff780.PubMed CentralView ArticlePubMedGoogle Scholar
- Martin I, Grotewiel MS: Oxidative damage and age-related functional declines. Mech Ageing Dev. 2006, 127: 411-423.View ArticlePubMedGoogle Scholar
- Lindahl T, Wood RD: Quality control by DNA repair. Science. 1999, 286: 1897-1905. 10.1126/science.286.5446.1897.View ArticlePubMedGoogle Scholar
- Ide H, Kotera M: Human DNA glycosylases involved in the repair of oxidatively damaged DNA. Biol Pharm Bull. 2004, 27: 480-485. 10.1248/bpb.27.480.View ArticlePubMedGoogle Scholar
- Dizdaroglu M: Base-excision repair of oxidative DNA damage by DNA glycosylases. Mutat Res. 2005, 591: 45-59.View ArticlePubMedGoogle Scholar
- Hazra TK, Das A, Das S, Choudhury S, Kow YW, Roy R: Oxidative DNA damage repair in mammalian cells: a new perspective. DNA Repair (Amst). 2007, 6: 470-480. 10.1016/j.dnarep.2006.10.011.View ArticleGoogle Scholar
- Morland I, Rolseth V, Luna L, Rognes T, Bjoras M, Seeberg E: Human DNA glycosylases of the bacterial Fpg/MutM superfamily: an alternative pathway for the repair of 8-oxoguanine and other oxidation products in DNA. Nucleic Acids Res. 2002, 30: 4926-4936. 10.1093/nar/gkf618.PubMed CentralView ArticlePubMedGoogle Scholar
- Takao M, Kanno S, Kobayashi K, Zhang QM, Yonei S, Horst van der GT, Yasui A: A back-up glycosylase in Nth1 knock-out mice is a functional Nei (endonuclease VIII) homologue. J Biol Chem. 2002, 277: 42205-42213. 10.1074/jbc.M206884200.View ArticlePubMedGoogle Scholar
- Rosenquist TA, Zaika E, Fernandes AS, Zharkov DO, Miller H, Grollman AP: The novel DNA glycosylase, NEIL1, protects mammalian cells from radiation-mediated cell death. DNA Repair (Amst). 2003, 2: 581-591. 10.1016/S1568-7864(03)00025-9.View ArticleGoogle Scholar
- Krokeide SZ, Bolstad N, Laerdahl JK, Bjoras M, Luna L: Expression and purification of NEIL3, a human DNA glycosylase homolog. Protein Expr Purif. 2009, 65: 160-164. 10.1016/j.pep.2008.11.014.View ArticlePubMedGoogle Scholar
- Takao M, Oohata Y, Kitadokoro K, Kobayashi K, Iwai S, Yasui A, Yonei S, Zhang QM: Human Nei-like protein NEIL3 has AP lyase activity specific for single-stranded DNA and confers oxidative stress resistance in Escherichia coli mutant. Genes Cells. 2009, 14: 261-270. 10.1111/j.1365-2443.2008.01271.x.View ArticlePubMedGoogle Scholar
- Torisu K, Tsuchimoto D, Ohnishi Y, Nakabeppu Y: Hematopoietic Tissue-Specific Expression of Mouse Neil3 for Endonuclease VIII-Like Protein. J Biochem. 2005, 138 (6): 763-772. 10.1093/jb/mvi168.View ArticlePubMedGoogle Scholar
- Rolseth V, Runden-Pran E, Luna L, McMurray C, Bjoras M, Ottersen OP: Widespread distribution of DNA glycosylases removing oxidative DNA lesions in human and rodent brains. DNA Repair (Amst). 2008, 7: 1578-1588. 10.1016/j.dnarep.2008.06.007.View ArticleGoogle Scholar
- Kauffmann A, Rosselli F, Lazar V, Winnepenninckx V, Mansuet-Lupo A, Dessen P, Oord van den JJ, Spatz A, Sarasin A: High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene. 2008, 27: 565-573. 10.1038/sj.onc.1210700.View ArticlePubMedGoogle Scholar
- Nothias JY, Majumder S, Kaneko KJ, DePamphilis ML: Regulation of gene expression at the beginning of mammalian development. J Biol Chem. 1995, 270: 22077-22080. 10.1074/jbc.270.38.22077.View ArticlePubMedGoogle Scholar
- Schultz RM: The molecular foundations of the maternal to zygotic transition in the preimplantation embryo. Hum Reprod Update. 2002, 8: 323-331. 10.1093/humupd/8.4.323.View ArticlePubMedGoogle Scholar
- Hamatani T, Carter MG, Sharov AA, Ko MS: Dynamics of global gene expression changes during mouse preimplantation development. Dev Cell. 2004, 6: 117-131. 10.1016/S1534-5807(03)00373-3.View ArticlePubMedGoogle Scholar
- Wang QT, Piotrowska K, Ciemerych MA, Milenkovic L, Scott MP, Davis RW, Zernicka-Goetz M: A genome-wide study of gene activity reveals developmental signaling pathways in the preimplantation mouse embryo. Dev Cell. 2004, 6: 133-144. 10.1016/S1534-5807(03)00404-0.View ArticlePubMedGoogle Scholar
- Wang S, Cowan CA, Chipperfield H, Powers RD: Gene expression in the preimplantation embryo: in-vitro developmental changes. Reprod Biomed Online. 2005, 10: 607-616.View ArticlePubMedGoogle Scholar
- Gillies K, Price DJ: Cell migration and subplate loss in explant cultures of murine cerebral cortex. Neuroreport. 1993, 4: 911-914. 10.1097/00001756-199307000-00018.View ArticlePubMedGoogle Scholar
- Levers TE, Edgar JM, Price DJ: The fates of cells generated at the end of neurogenesis in developing mouse cortex. J Neurobiol. 2001, 48: 265-277. 10.1002/neu.1056.View ArticlePubMedGoogle Scholar
- Rao MS, Jacobson M: Developmental Neurobiology. 2005, Kluwer Academic/Plenum Publishers, 4View ArticleGoogle Scholar
- Tan SS, Kalloniatis M, Sturm K, Tam PP, Reese BE, Faulkner-Jones B: Separate progenitors for radial and tangential cell dispersion during development of the cerebral neocortex. Neuron. 1998, 21: 295-304. 10.1016/S0896-6273(00)80539-5.View ArticlePubMedGoogle Scholar
- Heins N, Malatesta P, Cecconi F, Nakafuku M, Tucker KL, Hack MA, Chapouton P, Barde YA, Gotz M: Glial cells generate neurons: the role of the transcription factor Pax6. Nat Neurosci. 2002, 5: 308-315. 10.1038/nn828.View ArticlePubMedGoogle Scholar
- Noctor SC, Flint AC, Weissman TA, Wong WS, Clinton BK, Kriegstein AR: Dividing precursor cells of the embryonic cortical ventricular zone have morphological and molecular characteristics of radial glia. J Neurosci. 2002, 22: 3161-3173.PubMedGoogle Scholar
- Spassky N, Merkle FT, Flames N, Tramontin AD, Garcia-Verdugo JM, varez-Buylla A: Adult ependymal cells are postmitotic and are derived from radial glial cells during embryogenesis. J Neurosci. 2005, 25: 10-18. 10.1523/JNEUROSCI.1108-04.2005.View ArticlePubMedGoogle Scholar
- Malatesta P, Appolloni I, Calzolari F: Radial glia and neural stem cells. Cell Tissue Res. 2008, 331: 165-178. 10.1007/s00441-007-0481-8.View ArticlePubMedGoogle Scholar
- Lois C, Alvarez-Buylla A: Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci USA. 1993, 90: 2074-2077. 10.1073/pnas.90.5.2074.PubMed CentralView ArticlePubMedGoogle Scholar
- Alvarez-Buylla A, Garcia-Verdugo JM: Neurogenesis in adult subventricular zone. J Neurosci. 2002, 22: 629-634.PubMedGoogle Scholar
- Duan X, Kang E, Liu CY, Ming GL, Song H: Development of neural stem cell in the adult brain. Curr Opin Neurobiol. 2008, 18: 108-115. 10.1016/j.conb.2008.04.001.PubMed CentralView ArticlePubMedGoogle Scholar
- Gage FH: Mammalian neural stem cells. Science. 2000, 287: 1433-1438. 10.1126/science.287.5457.1433.View ArticlePubMedGoogle Scholar
- Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, Espeseth AS: Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe. 2008, 4: 495-504. 10.1016/j.chom.2008.10.004.View ArticlePubMedGoogle Scholar
- Machon O, Bout van den CJ, Backman M, Rosok O, Caubit X, Fromm SH, Geronimo B, Krauss S: Forebrain-specific promoter/enhancer D6 derived from the mouse Dach1 gene controls expression in neural stem cells. Neuroscience. 2002, 112: 951-966. 10.1016/S0306-4522(02)00053-2.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.